Artemis II Nears Earth Return; Psychedelic Brain Study Findings Released
NASA's Artemis II mission is in its final hours, with four astronauts aboard the Orion capsule 'Integrity' completing a 685,000-mile journey around the Moon — the farthest humans have traveled in space. Separately, an international research consortium led by McGill University has published findings identifying common brain activity patterns produced by multiple psychedelic substances including psilocybin, LSD, DMT, mescaline, and ayahuasca.
Progressive outlets are likely to highlight the psychedelic research as evidence supporting expanded investment in alternative mental health treatments, and to celebrate the international, diverse Artemis II crew as a milestone in inclusive space exploration.
The factual record shows that Artemis II completed a lunar flyby mission and is executing its scheduled Earth reentry, while a peer-reviewed multi-country brain imaging study has documented shared neural signatures across several psychedelic compounds.
Conservative outlets are likely to emphasize NASA's engineering achievement and national pride in the Artemis program's successful lunar mission, while treating the psychedelic research with caution given the substances' controlled legal status.
The factual record shows that Artemis II completed a lunar flyby mission and is executing its scheduled Earth reentry, while a peer-reviewed multi-country brain imaging study has documented shared neural signatures across several psychedelic compounds.
Artemis II astronauts Reid Wiseman, Victor Glover, Christina Koch, and Jeremy Hansen are returning to Earth after the farthest crewed spaceflight in history, while McGill University-led researchers published the largest brain imaging study to date on psychedelic substances.